🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSingapore HSA regulations — anyone have experience? Page 5

Singapore HSA regulations — anyone have experience?

ingrid_STO Tue, Feb 24, 2026 at 3:39 AM 27 replies 1,196 viewsPage 5 of 6
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Mar 6, 2026 at 12:00 AM#21
andrew_nyc said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Adding the part of the answer the thread has not reached. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

9 7DebRD_ATL, KristenIndy, MarkLI_maint and 6 others
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 7, 2026 at 7:57 PM#22

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

I would rather be corrected than agreed with, if it comes to it.

10 8Dr.AddMedPHL, newstart_MO, mia_MS2 and 7 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Mar 9, 2026 at 3:53 PM#23

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

11 9SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Mar 11, 2026 at 11:48 AM#24
DoseLogDan said:
One practical note: write down what you did and when, before you need it.

This is where I part company with the consensus forming above. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

12 10amsterdam_pete, LondonLisa, mike_nyc and 9 others
Reply Quote Save Share Report
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Mar 13, 2026 at 7:42 AM#25
DoseLogDan said:
One practical note: write down what you did and when, before you need it.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Last edited: Mar 13, 2026 at 8:42 AM
13 11quinn_sf, NurseLeah_Nash, gary_naperville and 10 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register